Mr Cameron L Thompson, BS ACT | |
1807 Williams St, Sturgis, SD 57785-1142 | |
(605) 347-3003 | |
Not Available |
Full Name | Mr Cameron L Thompson |
---|---|
Gender | Male |
Speciality | Counselor - Professional |
Location | 1807 Williams St, Sturgis, South Dakota |
Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1073371167 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
101YP2500X | Counselor - Professional | 8685 (South Dakota) | Primary |
Mailing Address | Practice Location Address |
---|---|
Mr Cameron L Thompson, BS ACT 1807 Williams St, Sturgis, SD 57785-1142 Ph: (605) 347-3003 | Mr Cameron L Thompson, BS ACT 1807 Williams St, Sturgis, SD 57785-1142 Ph: (605) 347-3003 |
News Archive
CaridianBCT, a leading global provider of technology, products and services in automated blood collections, therapeutic apheresis and cell therapy systems, whole blood processes and pathogen reduction technologies announced it has received 510(k) clearance for the Trima Accel® Automated Blood Collection System Version 6.0—providing increased efficiencies and streamlined operations to blood centers.
Alphatec Holdings, Inc., the parent company of Alphatec Spine, Inc., a medical device company that designs, develops, manufactures and markets products for the surgical treatment of spine disorders, with a focus on treating conditions related to the aging spine, announced today financial results for the first quarter March 31, 2010.
ChemoCentryx, Inc., today announced that it reported positive Phase I results for its novel drug candidate CCX354 at the Annual European Congress of Rheumatology (EULAR). CCX354 is the Company's orally-active small molecule drug candidate designed to specifically target the CCR1 chemokine receptor for the treatment of patients with rheumatoid arthritis (RA).
The Baltimore Sun on Friday examined how Democrats' takeover of Congress and the expiration of a law that requires drug manufacturers to pay user fees to FDA "is driving a flurry of activity that could lead to major changes" in the agency's drug safety policies.
› Verified 3 days ago
Sara Ellington, ACT, BS Counselor Medicare: Not Enrolled in Medicare Practice Location: 1807 Williams St, Sturgis, SD 57785 Phone: 605-347-2991 | |
Raffaella Rainieri, LAC Counselor Medicare: Not Enrolled in Medicare Practice Location: 1807 Williams St, Sturgis, SD 57785 Phone: 605-347-3003 | |
Bonnie Grace Sorzano, ACT Counselor Medicare: Not Enrolled in Medicare Practice Location: 1807 Williams St, Sturgis, SD 57785 Phone: 605-347-2991 | |
Ashlee Pray, BS, ACT Counselor Medicare: Not Enrolled in Medicare Practice Location: 1807 Williams St, Sturgis, SD 57785 Phone: 605-347-3003 | |
Georgia Bissonette, Counselor Medicare: Not Enrolled in Medicare Practice Location: 1807 Williams St, Sturgis, SD 57785 Phone: 605-347-3003 | |
Luke Everet Johnson, Counselor Medicare: Not Enrolled in Medicare Practice Location: 1807 Williams St, Sturgis, SD 57785 Phone: 605-347-3003 |